1.Datta, SD et al. (2007) Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Annals of Internal Medicine 147, 89–96.
2.Harling, G et al. (2013) Socioeconomic disparities in sexually transmitted infections among young adults in the United States: examining the interaction between income and race/ethnicity. Sexually Transmitted Diseases 40, 575–581.
3.Zeki Al Hazzouri, A et al. (2011) Life-course socioeconomic position and incidence of dementia and cognitive impairment without dementia in older Mexican Americans: results from the Sacramento area Latino study on aging. American Journal of Epidemiology 173, 1148–1158.
4.Barnholtz-Sloan, J et al. (2009) Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes & Control: CCC 20, 1129–1138.
5.Yu, D et al. (2014) Maternal socioeconomic status and the risk of congenital heart defects in offspring: a meta-analysis of 33 studies. PLoS One 9, e111056.
6.Pollitt, RA, Rose, KM and Kaufman, JS (2005) Evaluating the evidence for models of life course socioeconomic factors and cardiovascular outcomes: a systematic review. BMC Public Health 5, 7.
7.Geng, Y et al. (2017) Racial-ethnic differences in fall prevalence among older women: a cross-sectional survey study. BMC Geriatrics 17, 65.
8.Adler, NE and Newman, K (2002) Socioeconomic disparities in health: pathways and policies. Health Affairs 21, 60–76.
9.Kivimäki, M et al. (2018) The Routledge International Handbook of Psychosocial Epidemiology. Abingdon, Oxon; New York, NY: Routledge.
10.Dowd, JB, Zajacova, A and Aiello, A (2009) Early origins of health disparities: burden of infection, health, and socioeconomic status in U.S. children. Social Science & Medicine 68, 699–707.
11.Zajacova, A, Dowd, JB and Aiello, AE (2009) Socioeconomic and race/ethnic patterns in persistent infection burden among U.S. adults. The Journals of Gerontology Series A, Biological Sciences and Medical Sciences 64, 272–279.
12.Dowd, JB, Aiello, AE and Alley, DE (2009) Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiology and Infection 137, 58–65.
13.Feinstein, L et al. (2016) Does cytomegalovirus infection contribute to socioeconomic disparities in all-cause mortality? Mechanisms of Ageing and Development 158, 53–61.
14.Itzhaki, RF (2014) Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus. Frontiers in Aging Neuroscience 6, 202.
15.Pawelec, G et al. (2005) Human immunosenescence: is it infectious? Immunological Reviews 205, 257–268.
16.Roberts, ET et al. (2010) Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. American Journal of Epidemiology 172, 363–371.
17.Medzhitov, R (2008) Origin and physiological roles of inflammation. Nature 454, 428–435.
18.Nazmi, A et al. (2010) The influence of persistent pathogens on circulating levels of inflammatory markers: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis. BMC Public Health 10, 706.
19.Epstein, SE et al. (2000) Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arteriosclerosis, Thrombosis, and Vascular Biology 20, 1417–1420.
20.Epstein, SE (2002) The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circulation Research 90, 2–4.
21.Zhu, J et al. (2000) Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. The American Journal of Cardiology 85, 140–146.
22.Dowd, JB et al. (2013) Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6–19, 2003–2010. PLoS One 8, e64921.
23.Simanek, AM, Dowd, JB and Aiello, AE (2009) Persistent pathogens linking socioeconomic position and cardiovascular disease in the US. International Journal of Epidemiology 38, 775–787.
24.McQuillan, GM et al. (2004) Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: data from NHANES III, 1988–1994. American Journal of Public Health 94, 1952–1958.
25.Grad, YH, Lipsitch, M and Aiello, AE (2012) Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities. American Journal of Epidemiology 175, 54–59.
26.Simanek, AM et al. (2015) Unpacking the ‘black box’ of total pathogen burden: is number or type of pathogens most predictive of all-cause mortality in the United States? Epidemiology and Infection 143, 2624–2634.
27.Curtin, LR et al. (2012) The national health and nutrition examination survey: sample design, 1999–2006. Vital and Health Statistics Series 2, Data Evaluation and Methods Research 155, 1–39.
28.Curtin, LR et al. (2013) National health and nutrition examination survey: sample design, 2007–2010. Vital and Health Statistics Series 2, Data Evaluation and Methods Research 160, 1–23.
32.Evans, GW and Kantrowitz, E (2002) Socioeconomic status and health: the potential role of environmental risk exposure. Annual Review of Public Health 23, 303–331.
33.Cohen, S (1999) Social status and susceptibility to respiratory infections. Annals of the New York Academy of Sciences 896, 246–253.
34.Cohen, S et al. (2013) Childhood socioeconomic status, telomere length, and susceptibility to upper respiratory infection. Brain, Behavior, and Immunity 34, 31–38.
35.Meier, HCS et al. (2016) Early life socioeconomic position and immune response to persistent infections among elderly Latinos. Social Science & Medicine 166, 77–85.
36.Stringhini, S et al. (2015) Life-course socioeconomic status and DNA methylation of genes regulating inflammation. International Journal of Epidemiology 44, 1320–1330.
37.Dowd, JB and Aiello, AE (2009) Socioeconomic differentials in immune response. Epidemiology 20, 902–908.